April 2022Analysis of a real-world progression variable and related endpoints for patients with five different cancer typesMethodologyBreast cancerKidney cancerSkin cancerLung cancerReal-World DataGastric cancer
June 2019Using real-world cohorts to assess the generalizability and relevance of randomized clinical trialsHealth equityMethodologyBreast cancerHematologic malignanciesKidney cancerLung cancerBladder cancer
June 2019Organ dysfunction and clinical outcomes in patients treated with immune checkpoint inhibitorsUnmet needHead and neck cancerKidney cancerSkin cancerLung cancerGastric cancer
April 2019Development and initial validation of a prognostic score based on structured data from EHRsMethodologyHead and neck cancerKidney cancerSkin cancerLung cancerBladder cancer
May 2018Speed of adoption of immune checkpoint inhibitors of programmed cell death 1 protein and comparison of patient ages in clinical practice vs pivotal clinical trialsMethodologyKidney cancerSkin cancerLung cancerTreatment and Testing patterns
June 2017Racial disparities in the use of programmed death-1 checkpoint inhibitorsHealth equityKidney cancerSkin cancerLung cancer
April 2017Chemotherapy use near end of life (EOL): measuring real world benchmarksBreast cancerColorectal cancerPancreatic cancerKidney cancerLung cancerGastric cancerTreatment and Testing patterns